Document Detail

Clinical and hemodynamic effects of dobutamine in acute myocardial infarction with left heart failure.
MedLine Citation:
PMID:  6157948     Owner:  NLM     Status:  MEDLINE    
We studied the clinical and hemodynamic effects of dobutamine infused for 24 hr into 10 patients with acute myocardial infarction (less than 4 days) complicated by left heart failure (pulmonary wedge pressure greater than 15 mm Hg, cardiac index less than 3.0 liters/min/m2). We measured pulmonary arterial pressures, pulmonary wedge pressure, right atrial pressure, and intravascular systemic blood pressures. The thermodilution method was used for determinations of cardiac output, and the electrocardiogram was followed with a computerized arrhythmia monitoring system. After 1 and 3 hr of infusion with the optimal dose (averaging 8 micron/kg/min), there was a very significant increase of cardiac index (29%) and a decrease of pulmonary wedge pressure (37%) with a moderate increase of heart rate (20%) an without significant changes in blood pressure. After 24 hr of dobutamine infusion, much of the improvement in left ventricular function was lost. This may be attributed either to a decrease of drug action or to an unfavorable evolution of the clinical status. We conclude that infusion of dobutamine is an effective, potent, and well-tolerated short-term procedure in the management of left heart failure during the acute stage of myocardial infarction.
M Renard; R Bernard
Related Documents :
2353618 - Long-term oral diazoxide therapy for pulmonary vascular obstructive disease associated ...
413688 - Influence of indomethacin on the systemic and pulmonary vascular resistance in man.
19353678 - The effect of short-term isometric muscle contraction and the valsalva maneuver on syst...
3356668 - A model for hypoxic constriction of the pulmonary circulation.
19143128 - Effect of increased intra-abdominal pressure due to pneumoperitoneum on liver functions...
12349898 - Dietary vitamin e supplementation lowers blood pressure in spontaneously hypertensive r...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  2     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1980 Sep-Oct
Date Detail:
Created Date:  1980-11-25     Completed Date:  1980-11-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  543-52     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Catecholamines / therapeutic use*
Dobutamine / adverse effects,  therapeutic use*
Heart Failure / drug therapy*,  etiology
Hemodynamics / drug effects*
Middle Aged
Myocardial Infarction / complications,  drug therapy*
Time Factors
Reg. No./Substance:
0/Catecholamines; 34368-04-2/Dobutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pirmenol hydrochloride (CI-845): antiarrhythmic profile in coronary artery ligated conscious dogs.
Next Document:  Effects of commonly used cardioactive drugs on atrial and sinoatrial conduction in man.